Free Trial

Heron Therapeutics (HRTX) SEC Filings & 10K Form

Heron Therapeutics logo
$1.19 -0.05 (-4.03%)
(As of 11/15/2024 ET)

Recent Heron Therapeutics SEC Filings

DateFilerForm TypeView
11/12/2024
8:32 AM
Adage Capital Management, L.P. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G
11/06/2024
1:08 PM
Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/05/2024
11:41 AM
Heron Therapeutics (Issuer)
Kaseta Michael (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
11/04/2024
4:09 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/24/2024
1:02 PM
BlackRock, Inc. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G
10/21/2024
2:49 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/21/2024
2:53 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2024
3:35 PM
Heron Therapeutics (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
07/22/2024
8:44 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
8:54 AM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/22/2024
8:32 AM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2024
7:44 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/18/2024
3:43 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/17/2024
1:21 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
06/07/2024
8:34 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/31/2024
10:08 AM
Heron Therapeutics (Subject)
Rubric Capital Management LP (Filed by)
Form SC 13D/A
05/29/2024
7:05 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:05 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
05/07/2024
7:05 AM
Heron Therapeutics (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
04/29/2024
1:33 PM
Heron Therapeutics (Filer)
Form DEF 14A
04/29/2024
1:36 PM
Heron Therapeutics (Filer)
Form ARS
04/19/2024
4:48 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:02 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
04/19/2024
4:21 PM
Heron Therapeutics (Filer)
Form PRE 14A
04/19/2024
3:34 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/21/2024
3:32 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2024
7:46 AM
Deep Track Capital, LP (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
02/06/2024
10:43 AM
FRANKLIN RESOURCES INC (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
01/24/2024
7:01 AM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/19/2024
7:58 PM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:00 PM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:01 PM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:01 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:02 PM
Dissanaike Sharmila (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:03 PM
Heron Therapeutics (Issuer)
Johnson Craig A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:04 PM
Heron Therapeutics (Issuer)
Morgan Adam (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:04 PM
Heron Therapeutics (Issuer)
Rodriguez Susan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/19/2024
8:05 PM
Christian Waage (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
01/16/2024
4:19 PM
Heron Therapeutics (Issuer)
Peraza Lisa (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/11/2024
3:07 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/22/2023
3:30 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
Let’s be blunt (Ad)

Let me be blunt with you for just a second… You may think you know when and why stocks move, but you’re wrong… Most traders have no idea about the biggest secret Wall Street keeps — even though it’s hiding in plain sight. But once you’ve cracked this code… It could be the breakthrough you need to start targeting $100-$150 a day in the stock market (starting with just $1,000)!

12/21/2023
4:25 PM
Heron Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/07/2023
1:45 PM
Heron Therapeutics (Subject)
JPMORGAN CHASE & CO (Filed by)
JPMORGAN CHASE & CO (Filed by)
Form SC 13G/A
12/06/2023
3:47 PM
BlackRock Inc. (Filed by)
Heron Therapeutics (Subject)
Form SC 13G/A
11/21/2023
11:19 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/20/2023
9:07 AM
Forbes William P (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:36 AM
Duarte Ira (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
11/17/2023
11:37 AM
Collard Craig A (Reporting)
Heron Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
(Data available from 1/1/2016 forward)


Related Companies and Tools


This page (NASDAQ:HRTX) was last updated on 11/17/2024 by MarketBeat.com Staff
From Our Partners